To determine if these markers are acting together or independently to exert a survival effect, we looked for a correlation between IL-6 and NLR, selected because it was strongest SI marker from our study and the most popular SI marker studied, in NSCLC patients. This evidence concerns the gene IL6 and non-small cell lung carcinoma.